OncoCyte Corp (OCX)
2.67
-0.08
(-2.91%)
USD |
NASDAQ |
Nov 21, 16:00
2.65
-0.02
(-0.75%)
After-Hours: 20:00
OncoCyte Price to Book Value: 4.629 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.629 |
| November 20, 2024 | 4.768 |
| November 19, 2024 | 4.421 |
| November 18, 2024 | 4.559 |
| November 15, 2024 | 4.525 |
| November 14, 2024 | 4.854 |
| November 13, 2024 | 5.097 |
| November 12, 2024 | 5.201 |
| November 11, 2024 | 5.028 |
| November 08, 2024 | 4.958 |
| November 07, 2024 | 4.924 |
| November 06, 2024 | 4.924 |
| November 05, 2024 | 5.062 |
| November 04, 2024 | 5.028 |
| November 01, 2024 | 5.201 |
| October 31, 2024 | 5.253 |
| October 30, 2024 | 5.236 |
| October 29, 2024 | 5.374 |
| October 28, 2024 | 5.374 |
| October 25, 2024 | 5.270 |
| October 24, 2024 | 5.288 |
| October 23, 2024 | 5.461 |
| October 22, 2024 | 5.340 |
| October 21, 2024 | 5.409 |
| October 18, 2024 | 5.426 |
| Date | Value |
|---|---|
| October 17, 2024 | 5.409 |
| October 16, 2024 | 5.392 |
| October 15, 2024 | 5.409 |
| October 14, 2024 | 5.409 |
| October 11, 2024 | 5.288 |
| October 10, 2024 | 5.374 |
| October 09, 2024 | 5.322 |
| October 08, 2024 | 5.270 |
| October 07, 2024 | 5.218 |
| October 04, 2024 | 5.010 |
| October 03, 2024 | 4.104 |
| October 02, 2024 | 4.200 |
| October 01, 2024 | 4.118 |
| September 30, 2024 | 3.925 |
| September 27, 2024 | 1.697 |
| September 26, 2024 | 1.750 |
| September 25, 2024 | 1.726 |
| September 24, 2024 | 1.767 |
| September 23, 2024 | 1.856 |
| September 20, 2024 | 1.968 |
| September 19, 2024 | 1.767 |
| September 18, 2024 | 1.738 |
| September 17, 2024 | 1.832 |
| September 16, 2024 | 1.856 |
| September 13, 2024 | 1.814 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3921
Minimum
Dec 20 2022
17.01
Maximum
Feb 16 2021
2.942
Average
2.307
Median
Price to Book Value Benchmarks
| Fonar Corp | 0.624 |
| XWELL Inc | 1.206 |
| ProPhase Labs Inc | 0.4865 |
| Applied DNA Sciences Inc | 0.1316 |
| Veracyte Inc | 2.566 |
Price to Book Value Related Metrics
| PS Ratio | 40.59 |
| Price | 2.67 |
| Earnings Yield | -170.0% |
| Market Cap | 44.95M |